by The temperature controlled pharmaceutical containers market comprises active and passive containers that help control temperature sensitive pharmaceutical products within the required temperature range during storage, transportation and shipping. These containers find wide use for the storage and shipping of pharmaceutical products such as vaccines, insulin, biologics and other temperature sensitive drugs that require stringent temperature control.
The Global Temperature Controlled Pharmaceutical Containers Market is estimated to be valued at US$ 10.26 Billion in 2024 and is expected to exhibit a CAGR of 10% over the forecast period from 2024 to 2031.
Key Takeaways
Key players operating in the temperature controlled pharmaceutical containers market are Cold Chain Technologies, Va-Q-Tec AG, Pelican BioThermal Limited, SOFRIGAM GROUP, Sonoco, Inmark Packaging, Snyder Industries, ACH Foam Technologies, LLC, Cryopak Industries Inc., Saeplast, Exeltainer, OMEGA Engineering, Envirotainer Ltd, Klinge Corporation, American Aerogel Corporation.
Growing demand in the market:
The growing Temperature Controlled Pharmaceutical Containers Market Demand and biologics is driving the need for advanced temperature controlled packaging solutions. Increasing research and development activities in cell and gene therapy have also bolstered demand.
Global expansion of the market:
Leading players in the market are focusing on geographic and capacity expansions to strengthen their global supply chain and cater to the growing needs of the pharmaceutical industry. New partnerships and mergers and acquisitions are also expected to support revenue growth over the forecast period.
Market key trends
One of the key trends gaining traction in the temperature controlled pharmaceutical containers market is the growing adoption of intelligent and connected logistics solutions. Players are focusing on incorporating IoTbased tracking and monitoring devices and cloud analytics capabilities for real-time shipment visibility, data logging and exception alerts. This is allowing for proactive decision making and ensuring product quality and safety compliance. Growing demand for sustainable packaging solutions is also driving innovations in reuse and recyclable container designs. Adoption of advanced insulation materials with improved efficiency and tighter temperature control capabilities will further bolster the market over the coming years.
Porter’s Analysis
Threat of new entrants: Low economies of scale in production and industry regulations pose a threat to new players entering the market.
Bargaining power of buyers: Large healthcare systems and buyers have moderate bargaining power due to availability of alternative options.
Bargaining power of suppliers: Suppliers have moderate to high bargaining power due to specialized manufacturing requirements and limited substitutes.
Threat of new substitutes: Low threat of substitution with limited alternatives offering the combination of low temperature maintenance and breakage prevention during transit.
Competitive rivalry: High with focus on customizations, innovation, quality assurance and compliance with stringent regulations.
North America will continue dominating the temperature controlled pharmaceutical containers market, accounting for over 40% share through 2031, driven by favorable reimbursement policies and increasing healthcare spending. Rapidly ageing population triggering demand for pharmaceuticals and biologics will further fuel regional market growth. Asia Pacific will emerge as the fastest growing market, expanding at a CAGR of around 12% during the forecast period. Rising healthcare standards, growing middle class population and increasing contract manufacturing activities for pharmaceuticals in countries like India and China will drive the Asia Pacific temperature controlled pharmaceutical containers market.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
